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Abstract
Epilepsy is one of the most common chronic neurological diseases in veterinary practice. Magnetic resonance
imaging (MRI) is regarded as an important diagnostic test to reach the diagnosis of idiopathic epilepsy. However,
given that the diagnosis requires the exclusion of other differentials for seizures, the parameters for MRI examination
should allow the detection of subtle lesions which may not be obvious with existing techniques. In addition, there are
several differentials for idiopathic epilepsy in humans, for example some focal cortical dysplasias, which may only
apparent with special sequences, imaging planes and/or particular techniques used in performing the MRI scan. As a
result, there is a need to standardize MRI examination in veterinary patients with techniques that reliably diagnose
subtle lesions, identify post-seizure changes, and which will allow for future identification of underlying causes of
seizures not yet apparent in the veterinary literature.
There is a need for a standardized veterinary epilepsy-specific MRI protocol which will facilitate more detailed
examination of areas susceptible to generating and perpetuating seizures, is cost efficient, simple to perform and
can be adapted for both low and high field scanners. Standardisation of imaging will improve clinical communication
and uniformity of case definition between research studies. A 6–7 sequence epilepsy-specific MRI protocol for
veterinary patients is proposed and further advanced MR and functional imaging is reviewed.
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Background
Canine epilepsy has an estimated prevalence of 0.62–
0.75 % in primary veterinary practice [1, 2] and as such
is one of the most common chronic neurological
diseases. Magnetic resonance imaging (MRI) is regarded
as an essential diagnostic test however the specificity is
limited because the diagnosis of idiopathic epilepsy is
one of exclusion and the reliability of diagnosis is limited
by available technology and expertise in interpretation.
The International League against Epilepsy (ILAE) defines
idiopathic epilepsy as an epilepsy of predominately genetic
or presumed genetic origin and in which there is no gross
neuroanatomic or neuropathologic abnormality [3]. There-
fore by default, MRI examination of an animal with
idiopathic epilepsy should be “normal” (in human epilepsy
termed MRI–negative). However the ability to detect
lesions depends on many factors that affect the quality
of the MRI examination (Table 1). Some of these fac-
tors can be controlled, such as optimal slice thickness
and sequence. Other factors are less easy to influence.
For example, the ideal epilepsy protocol in humans
(Table 2) would include a gradient echo or similar tech-
nique for detecting haemorrhage or calcification. However
this sequence is sensitive to susceptibility artefacts arising
from the skull bones for example the mastoid area of the
temporal bone, which are a more significant problem in
veterinary patients that have a greater bone:brain ratio
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Table 1 Factors that have an effect on the ability to detect epileptic lesions on MRI
Type Example Notes
Protocol Slice thickness Thinner slices give more chance of lesion detection. A routine scan with 5 mm thick slices and 0.5 mm interslice gaps with T1W
and T2W transverse image acquisitions and gadolinium contrast enhancement may be adequate to evaluate gross cerebral
abnormalities such as large tumours or malformations but may not detect subtle epileptic lesions. Slice thickness of 3 mm or less
in at least 2 orientations is recommended for examination of the epileptic brain and larger slice size risks missing lesions less than
5 mm [38]. However MRI machines of 1 T or less cannot provide thin slices with sufficient SNR within reasonable time. For this reason
machines under 1.5 T are considered insufficient for the imaging of human epilepsy patients unless there is no alternative [38].
Sequence Failure or inability to select the appropriate sequences to detect lesions. For example in humans, high resolution, volumetric and 3D
MRI acquisition is recommended to obtained detailed information on hippocampal anatomy, cortical gyral patterns, improve grey and
white matter contrast and to enable co-registration with other modalities or sequential MRI examinations [13, 38]. This requires a good
quality machine (1.5 T or more) and careful orientation of slice plane relative to patient position. FLAIR sequence is regarded as the most
useful image for detecting epileptic lesions in humans [38] however many low field machines produce FLAIR with low resolution.
Magnetic field
strength
Low field versus high field Imaging with higher magnetic field-strength provides improved signal-to-noise ratio and spatial resolution which allows shorter
imaging times for a given resolution and/or higher resolution for a given imaging time. Higher signal-to-noise ratio allows
better resolution with smaller voxel size and thinner slice thickness [7].1.5 T versus 3 T
Coil Type of coil used (for example Knee vs Head
coil)
Coils with minimum distance between receiving coil and brain surface and minimal diameter increase SNR and therefore image
quality. Some coils (for example brain coils) may limit the field of view that can be imaged before significant signal drop-off occurs.
The lack of availability of dog-specific coils and variation in dog head size makes coil selection challenging in some cases.
Available channels An 8 channel brain coil is usual in veterinary MRI but a 32 channel brain coil will provide much better SNR and contrast resolution.
Operator
factors
Inexperience / lack of training A fully trained radiography technician understands the physics of MRI and anatomy allowing them to create images with excellent contrast
and clarity and target the brain structures to be studied. Typically, a trained MRI technician has undertaken a 3-year radiography degree plus
an additional 2–3 years of post-graduate MRI training. A poorly trained or unqualified operator may not be able to achieve optimal results
from the machine that they have. In veterinary medicine it is possible to operate a MRI service without a specialist qualification.
Diligence There are ways of improving image quality, for example increasing the number of averages (NEX) however these tend to increase
the acquisition time. Out with other reasons for decreasing imaging time (economic / duration of anaesthesia), operator
motivation is a factor. Bearing this in mind any recommended epilepsy-specific MRI protocol should not be overly onerous in order
to improve compliance. A basic protocol of 6 sequences is recommended [38].
Interpreter
factors
Inexperience / lack of training Failure to recognise significant lesions or over-interpretation of other features. A study in humans found that 61 % of epileptogenic
lesions remained undetected following “non-expert” reports of “standard” MRI scans. The failure rate dropped to 9 % using an
epilepsy tailored MRI protocol with interpretation by experienced neuro-radiologists [39].
Patient factors Skull and air interface In some machines may cause susceptibility artefacts on gradient echo and T1W 3D imaging
Small brain Slice thickness should be proportional to the brain volume to achieve images with diagnostic quality i.e. animals with smaller brain
volume require thinner slices.
Brain conformation Changes in skull shape, in particular brachycephaly have resulted in changes in brain conformation [40].
General anaesthetic Increased time under general anaesthesia may increase risk to patient.
Economic
factors
Time Increased time of scanning increases cost and risks of anaesthesia. It is important to consider the balance between time of
acquisition and image quality in an animal under general anaesthesia.
Machine costs (purchase of hardware, software,
housing and maintenance)
Imaging with higher magnetic field-strength allows for superior images in a shorter imaging time but at a greater cost.
Relevance Identification and localisation of epileptic lesion is vital in humans with drug-resistant epilepsy, who may be candidates for potentially
curative resective epilepsy surgery. Whether this is applicable for dogs with idiopathic epilepsy remains to be seen. Technology that is
only capable of detecting large structural pathology such as tumours may be sufficient if it does not alter the management. However
acquisition of high quality scans may enable future identification of resectable lesions that are currently hypothesised.
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than humans. The interface between bone and air can
cause inhomogeneity in the magnetic field and signal void
(susceptibility) artefact, particularly noticeable on special
sequences such as diffusion-weighted imaging (DWI) and
which can interfere with MR spectroscopic techniques.
The ability to detect epileptogenic lesions is further
limited by economics. For example, imaging with a 3
tesla (3 T) MRI system gives better anatomical detail
and is superior for detecting subtle lesions such as me-
sial temporal sclerosis [4] and migration disorders [5, 6].
However the initial and on-going cost of this technology
is prohibitive for many institutions and indeed much of
veterinary MRI is performed on low field (1 T or less)
scanners, which have decreased spatial resolution and
signal-to-noise ratio (SNR) [7].
Other technology may need to be employed to detect
lesions in MRI–negative patients. Methods of processing
MRI data post-acquisition have identified previously un-
detectable or overlooked abnormalities in humans [8, 9].
One such example is employed to improve hippocampal
volumetric measurements in the sparsely myelinated and
small brain of neonatal humans. To achieve this, contrast
is optimised by combining dual echo T2W and proton
density images [10]. In large part this is based upon the
fact that discovery of a surgically resectable lesion signifi-
cantly improves the prognosis in human drug-resistant
focal epilepsy, including abnormalities of the hippocampus
in the region of the mesial temporal lobe. As a result, if
the MRI is negative then further work-up, for example
with functional MR imaging, is engaged to help localize
the epileptogenic lesion [11–13]. Table 3 details examples
of the modalities used, none of which are established as
routine in animals. However before making recommenda-
tions for advanced imaging, the veterinary surgeon and
the owner must be clear about what is to be gained.
Unless the diagnostic procedure changes the outcome or
management there may be little achieved by subjecting an
animal to invasive and/or expensive procedures. For
example, Smith and others found that if an epileptic dog
was less than six years old and had a normal inter-ictal
neurological examination then there was a 97 % confi-
dence of a unremarkable low field brain MRI, making
diagnosis of idiopathic epilepsy very likely [14]. At present,
given the lack of surgical or other therapeutic techniques
available to improve prognosis over standard antiepileptic
therapy, more research is required to improve the diag-
nostic sensitivity of MRI and establish the value of such
therapeutic techniques.
The purpose of this article is to propose an epilepsy-
specific MRI protocol that will optimise detection of lesions
ruling out idiopathic epilepsy as a diagnosis, standardise the
diagnosis for entry into clinical trials and facilitate detection
of lesions which develop as a consequence of epilepsy, as
well as provide high quality data for future studies investi-
gating the pathophysiology of epilepsy.
Aim of advanced diagnostic imaging for animals with
epilepsy
There are three main aims of advanced diagnostic im-
aging of the epileptic animal: 1) to rule out causes of
epileptic seizures which may be treatable with means
other than antiepileptic therapy only (e.g. inflammatory
or infectious brain disease) 2) to identify lesions which
are caused by seizures but are not themselves the source
of seizures for example hippocampal sclerosis and 3) to
provide data to further advance the field of research into
the pathogenesis and/or treatment of epilepsy. Import-
antly, MRI must always be preceded by a thorough in-
vestigation including a good clinical history with clinical
and neurological examination (see Consensus Proposal
on the diagnostic approach to epilepsy in dogs). In
addition, the absence of lesions identifiable on MRI
examination does not indicate prognosis or which drugs
are most appropriate. However MRI may enable the detec-
tion of lesions that may be associated with drug-resistance
such as hippocampal sclerosis [5]. High resolution imaging
of the hippocampus is therefore paramount in humans but
the value of this remains undetermined in animals [15, 16].
Identification of the epileptogenic lesion
Most veterinary hospitals that offer advanced diagnostic
imaging use the same protocol for the epileptic brain as
for detection of gross intracranial pathology such as tu-
mours. This reflects the aim of the procedure, namely to
identify those lesions that have a different prognosis or
treatment to idiopathic epilepsy. In human medicine,
different MRI protocols are performed depending on
whether the patient is expected to have idiopathic or
structural epilepsy. Some might recommend that epileptic
Table 2 Epilepsy-specific MRI protocol for humans This
“essential” 6 sequence protocol allows the detection of virtually
all common epileptogenic lesion in humans and was proposed
after systemic analysis of 2740 patients in a epilepsy pre-surgery
program [13, 38, 41]
Human epilepsy-specific MRI protocol
Slice thickness 3 mm or less
➢ T2W - 2 sequence orientations for hippocampal angulation
● Perpendicular to the long axis of the hippocampus
● Along the long axis of the hippocampus
➢ FLAIR - 2 sequence orientations for hippocampal angulation
● Perpendicular to the long axis of the hippocampus
● Along the long axis of the hippocampus
➢ T1W
● 3D volume with 1 mm isotropic voxel size
➢ Hemosiderin/calcification sensitive sequences e.g. gradient echo
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Table 3 Novel imaging modalities for identifying epileptic foci
Modality Principle Veterinary application
Magnetoencephalography (MEG)
and magnetic source imaging (MSI)
MEG – non-invasive functional imaging recording magnetic flux on the head surface
associated with electrical currents in activated sets of neurons. MSI - created when
MEG data is superimposed on a MRI [42].
Has been performed experimentally in anaesthetised non-epileptic dog [43].
May be limited by requirement for anaesthesia [44].
Identity microchip may interfere with recording [45].
Requires a magnetically shielded room and other expensive equipment [12].
Positron Emission Tomography (PET) Functional representational of brain activity (dependent of the radionuclide tracer
utilised) e.g. local glucose utilisation (fluorine-18 fluorodeoxyglucose - FDG). Brain
regions containing the epileptogenic zone have hypometabolism on inter-ictal
FDG-PET [12]. PET and MRI co-registration or integrated PET/MR with simultaneous
acquisition is considered superior [8].
FDG-PET may be useful as a diagnostic test for idiopathic epilepsy in the
dog [46, 47]
Ictal and inter-ictal single-photon
emission computed tomography
(ictal/inter-ictal SPECT)
Injection of a radiolabeled tracer during ictus and inter-ictus. Statistical comparison
of the blood flow changes. Ideally co-registered to MRI (SISCOM) [48, 49].
Practical difficulties of performing in ictus. Has been performed in inter-ictus
and in one study demonstrated subcortical hypoperfusion in epileptic
dogs [50]
Diffusion tensor imaging (DTI) Detects tissue microstructural pathology that influences freedom of water
molecular diffusion. Has been used to detect hippocampal and temporal lobe
pathology in TLE and DTI tractography has been used in surgical planning [12].
Has demonstrated microstructural alterations in large white matter tracts in
idiopathic generalised epilepsy [51]
Experimental studies suggest DTI is feasible in dog [52–54] and structural
abnormalities have been identified in a compulsive behaviour disorder [55].
No application for epilepsy yet.
Functional magnetic resonance
imaging (fMRI)
Utilises the different magnetic susceptibilities of deoxygenated and oxygenated
haemoglobin (blood oxygenation level dependent (BOLD) contrast). Deoxygenated
haemoglobin is paramagnetic leading to distortion of magnetic fields and a
shorter T2 relaxation time. Areas of increased brain activity have greater metabolic
demand and more oxygenated haemoglobin and a prolonged T2 relaxation time.
The difference in BOLD at rest and during a specific task (such as language and
memory) indicates the areas of the brain activated by the task [12].
Laboratory experimental studies, none relating to epilepsy [56]. Has been
used in trained awake dogs to assess cognition [57–59].
fMRI-EEG EEG is acquired using a specialized system in the MRI machine while acquiring a
blood oxygenation level dependent (BOLD) sequence. The EEG is analysed for
epileptiform discharges spikes and the corresponding BOLD fMRI change is
evaluated [12].
None as yet
Functional connectivity MRI (FcMRI) Utilizes the principles of fMRI to demarcate brain networks. It evaluates the
structural changes distant from the epileptic focus. Main application is in
pathophysiology of the epilepsy but has the potential to guide surgery [12].
None as yet
Near infra-red spectroscopy (NIRS) Probe transmits near infra-red spectrum wavelength rays that passed through the
cranium to a depth of approximately 2 cm and is absorbed by haemoglobin in the
tissue. Reflected rays are detected by a sensor probe. The strength of reflected rays
is inversely related to the concentration of haemoglobin in the brain tissue. The
resulting images are co-registered to the MRI to lateralize and localize the signal
changes [12].
Pilot studies performed assessing positive emotional states in dogs [60]
Limited to superficial brain structures. May have limited application in dogs
with thicker skulls and muscle. However can be performed in awake
animals.
Magnetic resonance spectroscopy
(MRS)
MRS can be used to measure creatine (Cr), N-acetyl aspartate (NAA), choline (Cho),
lactate, myo-inositol and GABA non-invasively in the brain tissue [12]. Reduced
NAA/Cho and NAA/Cr was found in the lesional temporal lobe in TLE [61] and in
the epileptogenic/irritative zone in frontal lobe epilepsy [62]. These MRS changes
were most likely due to cell dysfunction than cell loss [12]
Studies in healthy dogs [63], laboratory canine model of seizures [64] and
in some disease states [65].
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Table 3 Novel imaging modalities for identifying epileptic foci (Continued)
Arterial spin labelling (ASL) ASL is a non-invasive MRI technique to assess brain perfusion and therefore image
functional areas of the brain. Arterial blood is magnetically labelled using a 180°
radio frequency (RF) inversion pulse prior to imaging the region of interest (ROI).
The labelled blood flows into the ROI and reduces the MR signal and image intensity
at this area. Subtracting this image from the baseline MRI creates the perfusion image
which reflects the amount of blood delivered to each voxel [12, 66]. It has been used
to show mesial temporal hypometabolism [67] and hippocampal volume loss [68]
None as yet
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animals that are not expected to have idiopathic epilepsy
(for example those animals younger than 6 months or
older than 6 years or those patients with abnormal inter-
ictal neurological examination) could be examined using
an MRI protocol that does not require as high a resolution
imaging of the brain while those patients expected to have
idiopathic epilepsy could be examined using a higher reso-
lution protocol. However in practice the expense and risk
associated with general anaesthesia in veterinary patients
makes it unlikely that more than one protocol be used for
scanning an animal with epileptic seizures. Therefore any
protocol developed for animals must be capable of diag-
nosing both types of epilepsy.
For animals with a probable diagnosis of idiopathic
epilepsy (i.e. those animals that fulfil Tier 1 level of confi-
dence for diagnosis - see Consensus Proposal: Diagnostic
approach to epilepsy in dogs), many of the differential
diagnoses associated with structural epilepsy, in particular
large malformations and neoplastic causes, are relatively
straightforward to identify [6, 17, 18]. However, several are
associated with subtle changes that may be easily missed
without adequate resolution scanning and careful inter-
pretation. The most common of these are listed in Table 4.
It must also be remembered that any lesion identified is
not automatically epileptogenic in nature and other
evidence (e.g. EEG, seizure history) may be required to
demonstrate this [19].
Identification of lesions which are the consequence of
seizures
Longitudinal studies of epileptic humans suggest that
10 % of newly diagnosed patients and 25 % of those with
chronic active epilepsy develop significant cerebral,
hippocampal or cerebellar atrophy over 3.5 years [20].
More acute changes secondary to seizures have also been
reported (Fig. 1) and it is important that imaging tech-
niques are able to differentiate these resultant, reversible
changes from those that may be the cause of seizures.
Most commonly, changes that are the result of seizures are
found as T2-weighted hyperintensities predominantly in
Fig. 1 Post-ictal changes in the temporal and parietal lobe. Images obtained in a 1.5 T Siemens Symphony, Erlangen, Germany. Post-ictal oedema
in the temporal lobe (short white arrow), hippocampus (long white arrow) and cingulate gyrus (yellow arrow) in a 2 year male English Bulldog that
presented in status epilepticus
Table 4 Differentials for idiopathic epilepsy that may require high resolution imaging to identify
Condition Imaging features References
Congenital and developmental causes
Nodular heteroptopia/ focal
cortical dysplasia
Abnormal location or thickness of deep grey matter, commonly periventricular or interspersed amongst
white matter.
[69]
L2-hydroxyglutaric aciduria Poor distinction between grey and white matter throughout cerebral hemispheres and deep grey matter.
Bilateral grey matter hyperintensity, especially the thalamus and cerebellum
[70]
Infectious and inflammatory causes
Distemper encephalitis Patchy, asymmetric T2-weighted hyperintensities with mild or no contrast enhancement on T1W scans.
Lesions are usually asymmetric, large, round to ovoid in shape throughout different parts of the forebrain,
especially in grey matter of the temporal lobe, as well as the brainstem, cerebellum and subcortical white
matter.
[71]
Rabies encephalitis Very mild lesions - bilaterally symmetrical T2W hyperintensities in temporal lobes, hippocampus,
hypothalamus, midbrain and pons with little or no contrast enhancement.
[72]
Metabolic, endocrine and nutritional causes
Hepatic encephalopathy Bilaterally symmetrical T1W hyperintensities in caudate nuclei, thalamus, not associated with contrast
enhancement
[73]
Thiamine deficiency Bilateral, symmetric T2W hyperintensities in caudate nuclei, lateral geniculate nuclei, red nucleus, caudal
colliculi, facial and vestibular nuclei
[74]
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the piriform and temporal lobes, as well as the cingulate
gyrus and hippocampus [21]. These changes resemble
those reported in humans and are likely to represent a
mixture of cytotoxic oedema and gliosis [21]. In some
cases mild contrast uptake may also be apparent [22]. In
general these changes are diffuse, relatively extensive, and
their characteristic location makes it straightforward to
distinguish them from epileptogenic lesions with either
high-field or low-field scanners. However sometimes in
can be difficult to ascertain if the changes are cause or
effect for example in VGKC-complex/LGI1 antibody-
associated limbic encephalitis in cats (Fig. 2) [23]. Cere-
brospinal fluid analysis can be unhelpful because post-ictal
pleocytosis can occur [24]. In ideal circumstances it would
be preferred to repeat imaging in the post ictal period and
also assess changes in brain volume/ atrophy however
available finances can limit this opportunity. In those pa-
tients with whom some doubt may remain, however, the
most useful procedure for identifying post-ictal MRI
changes is to repeat the scan at a later date, since these
changes resolve usually within 16 weeks [21].
Providing data for further research into the pathogenesis
and treatment of seizures
In humans, much attention has focussed on the hippo-
campus because temporal lobe epilepsy (TLE) is the
most common cause of complex focal epilepsy, and me-
sial temporal sclerosis (i.e. severe neuronal cell loss and
gliosis in the medial portion of the temporal lobe and
particularly in the hippocampus) is a major pathological
finding, occurring in roughly 50 % of TLE patients [25].
The pathogenesis of mesial temporal sclerosis is multi-
factorial and includes genetic factors and molecular
events such as channelopathies, activation of NMDA
receptors, and other conditions related to Ca(2+) influx
into neurons and imbalance of Ca(2+)-binding proteins
[26]. There has been much debate as to whether these
changes are the cause or the effect of seizures. Most sig-
nificantly, the surgical removal of these regions in patients
with an electroencephalographic (EEG) diagnosis that
confirms their location as the source of seizure activity
results in significant improvement in seizure control in
up to 80 % of patients [27, 28]. The current diagnosis
of hippocampal sclerosis in humans requires specific
positioning of slices in order to define the hippocampus
accurately, together with a considerable body of research
defining the range of normal volumes in healthy individ-
uals. These techniques for hippocampal measurement have
been established for many years and TLE is one of the
more common homogenous forms of epilepsy, so adequate
numbers of patients are available for studies [20].
Whether hippocampal volume loss and mesial tem-
poral sclerosis is a parameter that should be assessed in
dog has yet to be established (Fig. 1). Hippocampal atro-
phy has been demonstrated in rodent models [29] and in
familial spontaneous epileptic cats where EEG features
suggested TLE [16]. Reduced volume of the hippocampus /
hippocampal atrophy has been demonstrated in epileptic
dogs [15]. Furthermore histopathological changes consist-
ent with hippocampal sclerosis have been well described in
epileptic cats [28, 30, 31] (Figs. 2, 3). For these reasons, as
well as the recognition that hippocampal sclerosis repre-
sents a common surgical target in the treatment of human
epilepsy, it appears prudent to evaluate the hippocam-
pus accurately in animal patients with epilepsy. There-
fore routine MR evaluation of the epileptic subject
should at least include a visual assessment of the hippo-
campus for atrophy, asymmetry in size, loss of defined
morphologic structure, increased T2W or T2W Fluid
Attenuated Inversion Recovery (FLAIR) signal and
decreased T1W signal [15, 32]. Hippocampal T2W
hyperintensity is well correlated with pathology and
hippocampal sclerosis and measurement of the T2 re-
laxation time (T2 relaxometry) can provide an objective
measure in humans but has not been assessed in dogs or
cats [32]. There is an argument that volumetric studies
should be performed in veterinary patients (Table 5) and
recent studies have defined the range in normal animals
[33]. However making volumetric measurements is a
labour intensive process requiring high resolution MRI
Fig. 2 Hippocampal changes in an 8 month male neutered Oriental Shorthair presented with status epilepticus. a Transverse TW2 at level of
pituitary gland. There is hyperintensity of the right temporal lobe (red arrow) (b) Transverse FLAIR at level of pituitary gland also demonstrating
hyperintensity of the right temporal lobe (red arrow) (c) Transverse TW1 at level of pituitary gland. There is slight gadolinium contrast enhancement in
the mesial temporal lobe. Images reproduced with the kind permission of Dr Ane Uriarte . The cat was suspected to have limbic encephalitis
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and personnel training [33]. Currently this is only used as
a research tool, although in the future automated atlas-
based segmentation may make hippocampal volumetry
more routine. Even in humans where hippocampal volu-
metry has established utility, the time demands and re-
quired technical skills mean that it has been difficult to
integrate into clinical practice [34]. Consequently patients
with a surgically resectable lesion may be missed. This has
led to the development of automated software which will
Fig. 3 Hippocampal changes in a 22 month male neutered Oriental
Shorthair with drug-resitant epilepsy. Images obtained in a 1.5 T MRI
(Siemens Symphony, Erlangen, Germany) 12 months after the images
in Fig. 2. Despite an initial course of corticosteroids and polypharmacy
with multiple anti-convulsants the cat seizured on an almost daily
basis. a Dorsal T2W orientated perpendicular to long axis of the
hippocampus. b Transverse T2W orientated parallel to the long axis
of the hippocampus. c Dorsal FLAIR orientated perpendicular to
long axis of the hippocampus. d Transverse FLAIR orientated to
long axis of the hippocampus. e Dorsal T1W 3D images 1 mm slice
thickness orientated perpendicular to long axis of the hippocampus. f
Dorsal T1W orientated perpendicular to long axis of the hippocampus
post gadolinium. On FLAIR and T2W images there is reduction in
volume and a hyperintensity of the hippocampus (yellow arrows). With
the TIW 3D images it is possible to appreciate loss in definition between
the white and grey matter in addition to reduction in volume of the
hippocampus (blue arrow) There is no abnormal enhancement with
gadolinium contrast
Table 5 Reasons why it may be appropriate to perform
volumetric studies on hippocampus or other potentially
epileptogenic areas
Rationale for volumetric analysis
➢ To establish normative date
● Breed and size variations
● Age
● Gender
● Within subject functional and anatomical asymmetry [75]
➢ To provide a baseline
● At initial diagnosis and for serial comparison, for example, if
develops drug-resistant epilepsy
➢ To identify patients with poor prognosis / less likely to
respond to treatment
● Volume compared to normative data
● Within subject asymmetry in volume
➢ Improving cohort selection for entry into clinical trials
evaluating
● Antiepileptic drugs
● Neuro-protective agents that may modulate the
consequences of epilepsy on cognition and behaviour [76]
● Novel treatment modalities
Table 6 Proposed epilepsy-specific MRI protocol for a high field
machine
Veterinary epilepsy-specific protocol for 1.5 T MRI
Slice thickness 3 mm or less
➢ T2W – 3 sequence orientations
● Sagittal enabling identification long axis of the hippocampus
● Dorsal, perpendicular to the long axis of the hippocampus
● Transverse, parallel to the long axis of the hippocampus
➢ FLAIR 1–2 sequence orientations for hippocampal angulation
● Dorsal, perpendicular to the long axis of the hippocampus
● Transverse, parallel to the long axis of the hippocampus
(optional)
➢ T1W
● 3D technique at 1 mm isotropic voxel size (if possible) or
routine T1W dorsal, perpendicular to long axis of the
hippocampus
● T1W post paramagnetic contrast injection enhancement if
indicated by other pathology / desired by clinician
➢ Hemosiderin / calcification sensitive sequences e.g. gradient
echo
● Transverse, parallel to the long axis of the hippocampus
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compare an individual patient’s regional brain volumes
with a normative database, correcting for sex, head size,
and age [34]. Establishing automated software in veterin-
ary patients is challenging due to difficulties in automatic
brain extraction algorithms arising from the great vari-
ation is head shape and brain size and conformation.
Establishment of reference ranges for the three basic
canine brain shapes (dolicocephalic, mesaticephalic and
brachycephalic) may represent a suitable compromise.
Before making a recommendation of measurement of hip-
pocampal volumes in veterinary patients it should be
remembered that hippocampal sclerosis is not applicable
to all idiopathic generalised epilepsies in humans espe-
cially if the epileptogenic focus is not the temporal lobe
[35]. Repeated seizures will affect other structures patho-
logically including the amygdala, cerebral neocortex and
the cerebellum [20].
Existing MRI protocols
Current protocols vary substantially between institu-
tions. Polling of members of the international veterinary
epilepsy task force determined that all protocols cur-
rently include imaging in at least two orientations
(transverse and sagittal) and the majority in three planes
(dorsal, typically orientated parallel to hard palate rather
than perpendicular to the long axis of the hippocampus).
T2W, T2W FLAIR and T1W images pre and post para-
magnetic contrast (gadolinium based) are included as
standard in most protocols used by specialists who are
active in the veterinary field. This differs from human
epilepsy-specific MRI protocols where routine adminis-
tration of gadolinium contrast is considered to provide
little advantage for idiopathic or TLE and is reserved for
patients in whom there is concern for tumour, vascular
malformations, inflammation, and infectious disease or
when these are suspected based on review of non-contrast
studies [35]. Routine administration of gadolinium con-
trast in veterinary medicine has been questioned [36].
Other sequences currently included in “veterinary brain
protocols” vary between institutions and may include
Gradient Echo (GE), T1 weighted Inversion Recovery
(T1WIR), Diffusion Weighted Imaging (DWI) and Short
Tau Inversion Recovery (STIR) or other fat suppression
techniques.
This variation between institutions suggests a need for
a uniform veterinary epilepsy-specific MRI protocol that
can provide a solid platform for clinical communication
and comparability of case definition between research
studies. There is also an argument for an MRI protocol
that is optimized for epilepsy evaluation facilitating more
detailed examination of areas susceptible to generating
and perpetuating seizures such as the frontal and tem-
poral lobes and other structures likely to be evaluated at
post-mortem in patients who have died. Such a protocol
must acknowledge financial constraints, be tailored for
low or high field machines and also complement patho-
logical studies.
Consensus on epilepsy-specific MRI protocol
There is a need for a standardized veterinary epilepsy-
specific MRI protocol which will facilitate more detailed
examination of areas susceptible to generating and per-
petuating seizures, complement pathological studies, is
economical, simple to perform and can be adapted for
both low and high field machines. Standardisation of
Table 7 Proposed epilepsy specific MRI protocol for a low field
machine
Veterinary epilepsy-specific protocol for 0.2 T MRI
Slice thickness 4 mm or less
➢ T1W – 3 sequence orientations
● Sagittal enabling identification of the long axis of the
hippocampus
● Dorsal, perpendicular to the long axis of the hippocampus
● Transverse, parallel to the long axis of the hippocampus
➢ T2W - 2 sequence orientations for hippocampal angulation
● Dorsal, perpendicular to the long axis of the hippocampus
● Transverse, parallel to the long axis of the hippocampus
➢ FLAIR 1–2 sequence orientations for hippocampal
angulation
● Dorsal, perpendicular to the long axis of the hippocampus
● Transverse parallel to the long axis of the hippocampus
(optional)
➢ T1W post paramagnetic contrast enhancement
● If indicated by other pathology / desired by clinician
● Number of sequences determined by pathology
Fig. 4 Parasaggital slice in a veterinary epilepsy-specific protocol for
1.5 T MRI scanner. T2W parasagittal image of the brain demonstrating
a planned sequence parallel (yellow dotted line) and perpendicular (red
solid line) to the long axis of the hippocampus. Images obtained in a
1.5 T MRI (Siemens Symphony, Erlangen, Germany)
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Fig. 5 Veterinary epilepsy-specific protocol for high field MRI. Images obtained in a 1.5 T MRI (Siemens Symphony, Erlangen, Germany). Triplet of
MR images illustrating the positon of the parasagittal slice containing the hippocampus. Left. T2W parasagittal section demonstrating the hippocampus
for sequences orientated relative to the long axis. Middle. Dorsal FLAIR of the brain at the level of the orbits illustrating the position of the parasagittal
slice (green line). Right T2W transverse of the brain at the level of the hippocampus illustrating the position of the parasagittal slice (green line)
Fig. 6 Variation in appearance of the hippocampus in different skull shapes. a brachycephalic vs (b) mesocephalic vs (c) dolicocephalic with
orientation of transverse scans parallel to the long axis of the hippocampus
Fig. 7 Veterinary epilepsy-specific protocol for low field MRI. T1W parasagittal image (left) of the brain demonstrating a planned sequence orientated
parallel (green line) and perpendicular (red solid line) to the long axis of the hippocampus. It is easier to identify the hippocampus in T1W images from
a low field machine. For comparison the corresponding T2W parasagittal images are included (right). Images obtained in 0.2 T MRI (Esaote Grande,
Genova, Italy)
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imaging will improve clinical communication and uni-
formity of case definition between research studies. We
propose the following protocols (Tables 6 and 7). During
protocol set-up, it is recommended that different parame-
ters (such as flip angle) are trialed in order to obtain the
optimal balance between grey-white matter contrast and
SNR (for information on MR parameters for 0, 2, 1.5 and
3T see Additional files 1, 2 and 3). Both protocols start
with obtaining a sagittal sequence. Due to the difference
in anatomical definition this is a T2W sequence in high
field machines and T1W sequence in low field machines.
In addition to identifying gross structural pathology the
sagittal images allow assessment of cerebellar atrophy ac-
cording to the protocol described by Thames and others
[37]. Using parasagittal images the long axis of the hippo-
campus is identified (Figs. 4, 5, 6, 7, 8 and 9). The hippo-
campus forms the medial wall of the temporal horn of the
lateral ventricle and is delineated on parasagittal images
by the contrasting cerebrospinal fluid. After identification
of the hippocampus, T2W and sequences are orientated
parallel and perpendicular to the long axis of the hippo-
campus (Figs. 4 and 7). T2W and FLAIR are acknowl-
edged to be optimal for detection of epileptic lesions in
humans in particular hippocampal changes (Figs. 2 and 3)
and therefore in humans two FLAIR sequences would be
obtained [38], however, it is recognized that performing
two FLAIR sequences may increase scanning time signifi-
cantly therefore we recommend that at a minimum a dor-
sal FLAIR sequence perpendicular to the long axis of the
hippocampus is obtained with an option for an additional
transverse sequence parallel to the long axis of the hippo-
campus. In high field scanners a transverse gradient echo
or similar sequences sensitive to detection of hemosiderin
and / or calcification should be obtained. Like the other
images this transverse image is also orientated parallel to
the hippocampus. In low field scanners additional T1W
sequences are recommended (Table 5). Some high field
machines may be able to obtain good resolution 3D TW1
images (Figs. 3, 8 and 10). For these the acquired slice
thickness is 1 mm or less giving improved chance of lesion
detection, better white and grey matter definition and can
be processed after imaging into any anatomical plane in-
cluding oblique. Furthermore this will facilitate volumetric
measurements and to enable co-registration with other mo-
dalities or sequential MRI examinations [13, 38]. If this is
not possible then a dorsal T1W sequence oriented along
the long axis of the hippocampus is suggested. As indicated
above there is an argument against routine paramagnetic
Fig. 8 Veterinary epilepsy-specific protocol for high field MRI. The imaging time for 6 sequences (Figs. 8 and 9) on a 1.5 T MRI was 45 min. The
subject was an epileptic 16 month female Cocker spaniel (a) and (b) Transverse and parasagittal T2W image illustrating slice orientation. c Dorsal
T2W orientated perpendicular to long axis of the hippocampus (d) Dorsal FLAIR orientated perpendicular to long axis of the hippocampus (e)
Dorsal T1W 3D images1mm slice thickness orientated perpendicular to long axis of the hippocampus
Fig. 9 Veterinary epilepsy-specific protocol for high field MRI. a parasagittal T2W image illustrating slice orientation. b Transverse T2W orientated
parallel to the long axis of the hippocampus. c Transverse FLAIR orientated parallel to the long axis of the hippocampus. Images obtained in a
1.5 T MRI (Siemens Symphony, Erlangen, Germany)
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contrast administration however it is acknowledged that
many veterinary neurologists would feel a MRI study of an
epileptic patient was incomplete without this therefore
these sequences are an optional extra. However if pathology
was detected in the unenhanced study, post-gadolinium se-
quences would be indicated (Fig. 10). Recommended slice
thickness is 3 mm or less for high field machines and 4 mm
or less for low field machines. Such a protocol would give
6–7 sequences for a high field machine and 6–7 sequences
on a low field machine (not including optional paramag-
netic contrast enhancement).
Additional files
Additional file 1: MRI Parameters for epilepsy-specific protocol on
a 0.2 T machine.
Additional file 2: MRI Parameters for epilepsy-specific protocol on
a 1.5 T machine.
Additional file 3: MRI Parameters for epilepsy-specific protocol on
a 3 T machine.
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